Plains All American Pipeline, L.P. · PAA · FY2025 Q2 · Calendar Q3 2025
PAA sharpens crude focus after $3 billion NGL sale
The call supports a constructive but conditional view: the NGL sale, crude-focused strategy, Permian growth, and acquisition capacity could support earnings growth, while lower-half guidance, contract roll-offs, and execution risks temper the case.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about PAA FY2025 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
PAA completed the strategic shift away from NGLs through the sale of its Canadian NGL business, raised growth capex to $475 million, and increased its BridgeTex ownership. Management kept full-year EBITDA guidance but framed results toward the lower half of the range.
Guidance delta
Full-year 2025 EBITDA guidance was maintained, with results expected in the lower half of the $2.8-$2.95 billion range. Growth capital guidance increased to $475 million.
Key takeaways
- The NGL divestiture shifts PAA toward crude oil midstream and provides proceeds for reinvestment.
- Management highlighted Permian and South Texas volume growth, pipeline expansion, and bolt-on acquisitions.
- The key tension is between a confident growth plan and contract roll-offs, capex execution, and demand risks.
Management priorities
- Pursue bolt-on acquisitions using proceeds from the NGL sale.
- Expand pipeline capacity and lease connections in the Permian and South Texas.
- Support dividend growth with free cash flow while considering unit repurchases.
Follow PAA with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 11, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Buy | Buy | Maintain | Oct 9, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Sep 21, 2026 |
| Barclays | Underweight | Underweight | Maintain | Sep 21, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Sep 17, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Sep 10, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Sep 3, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 18, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Aug 17, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 15, 2026 |
| Goldman Sachs | Neutral | Sell | Upgrade | Jun 4, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 12, 2026 |
| Stifel | Buy | Buy | Maintain | Mar 6, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Oct 24, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jul 25, 2025 |
| Bernstein | Market Perform | Outperform | Downgrade | Feb 7, 2023 |
| Seaport Global | Buy | Neutral | Upgrade | Aug 1, 2022 |
| B of A Securities | Neutral | Underperform | Upgrade | Jul 19, 2022 |
| Credit Suisse | Outperform | Neutral | Upgrade | May 12, 2022 |
| Evercore ISI Group | Outperform | In Line | Upgrade | Nov 15, 2021 |
| SMBC Nikko | Outperform | Outperform | Maintain | Dec 3, 2020 |
| TD Securities | Buy | Buy | Maintain | Nov 3, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Apr 22, 2020 |
| Baird | Neutral | Outperform | Downgrade | Mar 9, 2020 |
| Bank of America | Buy | Buy | Maintain | Oct 23, 2019 |
| Piper Jaffray | Overweight | Overweight | Maintain | Jul 17, 2019 |
| Jefferies | Buy | Hold | Upgrade | Dec 20, 2018 |
| Stifel Nicolaus | Buy | Hold | Upgrade | Sep 24, 2018 |
| Deutsche Bank | Buy | Buy | Maintain | Apr 20, 2018 |
| BMO Capital | Outperform | Market Perform | Upgrade | Aug 28, 2017 |
| Guggenheim | Neutral | Neutral | Maintain | Apr 18, 2017 |
| Piper Sandler | Overweight | Neutral | Upgrade | Oct 13, 2016 |
| FBR Capital | Perform | Market Perform | Maintain | Sep 9, 2016 |
| Oppenheimer | Sector Perform | Outperform | Downgrade | Dec 21, 2015 |
| Scotia Howard Weil | Perform | Sector Perform | Maintain | Aug 24, 2015 |
| Wunderlich Securities | Hold | Buy | Downgrade | Aug 6, 2015 |
| Wunderlich | Hold | Buy | Downgrade | Aug 6, 2015 |
| Clarksons Platou | Outperform | Market Perform | Upgrade | Nov 25, 2013 |
| Clarkson Capital Markets | Outperform | Market Perform | Upgrade | Nov 25, 2013 |
| Ladenburg Thalmann | Buy | Neutral | Upgrade | Jun 25, 2013 |
| Global Hunter Securities | Buy | Accumulate | Maintain | Aug 15, 2012 |
| Canaccord Genuity | Hold | Hold | Maintain | May 17, 2012 |
| Morgan Keegan | Outperform | Outperform | Maintain | Feb 10, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $24.34. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Manav Gupta | $31 | $24.5 | +27.4% | Oct 9, 2026 |
| Jefferies | Julien Dumoulin-Smith | $27 | $24.42 | +10.9% | Oct 9, 2026 |
| UBS | Analyst unavailable | $28 | $25.27 | +15.0% | Sep 21, 2026 |
| Raymond James | Justin Jenkins | $27 | $25.37 | +10.9% | Sep 21, 2026 |
| Mizuho Securities | Gabriel Moreen | $30 | $25.37 | +23.3% | Sep 21, 2026 |
| Barclays | Theresa Chen | $24 | $25.37 | -1.4% | Sep 21, 2026 |
| Scotiabank | Analyst unavailable | $27 | $25.85 | +10.9% | Sep 10, 2026 |
| Morgan Stanley | Robert Kad | $26 | $24.16 | +6.8% | Aug 18, 2026 |
| RBC Capital | Elvira Scotto | $26 | $23.9 | +6.8% | Aug 17, 2026 |
| RBC Capital | Elvira Scotto | $23 | $24.31 | -5.5% | Jul 21, 2026 |
| Barclays | Analyst unavailable | $23 | $23.35 | -5.5% | Jul 16, 2026 |
| Mizuho Securities | Gabriel Moreen | $27 | $22.6 | +10.9% | Jun 8, 2026 |
| Goldman Sachs | Analyst unavailable | $24 | $22.91 | -1.4% | Jun 3, 2026 |
| Morgan Stanley | Analyst unavailable | $25 | $23.86 | +2.7% | May 20, 2026 |
| Scotiabank | Analyst unavailable | $24 | $21.99 | -1.4% | May 12, 2026 |
| Seaport Global | Analyst unavailable | $24 | $22.54 | -1.4% | May 4, 2026 |
| Barclays | Theresa Chen | $21 | $21.92 | -13.7% | Apr 10, 2026 |
| Stifel Nicolaus | Selman Akyol | $25 | $21.97 | +2.7% | Mar 6, 2026 |
| Scotiabank | Analyst unavailable | $23 | $19.24 | -5.5% | Feb 9, 2026 |
| Mizuho Securities | Analyst unavailable | $23 | $19.14 | -5.5% | Jan 23, 2026 |
| Morgan Stanley | Robert Kad | $21 | $17.32 | -13.7% | Nov 25, 2025 |
| Raymond James | Analyst unavailable | $22 | $16.82 | -9.6% | Oct 24, 2025 |
| Barclays | Analyst unavailable | $17 | $16.71 | -30.2% | Oct 7, 2025 |
| Morgan Stanley | Analyst unavailable | $20 | $17.42 | -17.8% | Aug 26, 2025 |
| J.P. Morgan | Jeremy Tonet | $20 | $17.87 | -17.8% | Aug 8, 2025 |
| UBS | Manav Gupta | $25 | $18.65 | +2.7% | Jul 15, 2025 |
| Mizuho Securities | Gabriel Moreen | $22 | $18.41 | -9.6% | Jun 18, 2025 |
| Morgan Stanley | Robert Kad | $23 | $16.94 | -5.5% | May 9, 2025 |
| Scotiabank | Analyst unavailable | $22 | $19 | -9.6% | Mar 6, 2025 |
| Wolfe Research | Keith Stanley | $22 | $18.88 | -9.6% | Jan 10, 2025 |
| Bank of America Securities | Jean Ann Salisbury | $18 | $17.47 | -26.0% | Oct 17, 2024 |
| UBS | Manav Gupta | $22 | $18.03 | -9.6% | Jul 2, 2024 |
| RBC Capital | Elvira Scotto | $18 | $17.45 | -26.0% | May 14, 2024 |
| Goldman Sachs | John Mackay | $16 | $17.98 | -34.3% | Apr 12, 2024 |
| Bernstein | Analyst unavailable | $14.5 | $12.62 | -40.4% | Feb 7, 2023 |
| Citigroup | Analyst unavailable | $14 | $11.7 | -42.5% | Dec 9, 2022 |
| Truist Financial | Analyst unavailable | $15 | $12.19 | -38.4% | Dec 2, 2022 |
| Stifel Nicolaus | Selman Akyol | $16 | $11.66 | -34.3% | Aug 14, 2022 |
| Credit Suisse | Spiro Dounis | $14 | $10.24 | -42.5% | May 12, 2022 |
| Wells Fargo | Analyst unavailable | $16 | $10.39 | -34.3% | Apr 28, 2022 |
| Morgan Stanley | Analyst unavailable | $15 | $10.54 | -38.4% | Apr 26, 2022 |
| Raymond James | Analyst unavailable | $13 | $11.32 | -46.6% | Apr 20, 2022 |
| Truist Financial | Tristan Richardson | $13 | $10.47 | -46.6% | Nov 5, 2021 |
| Citigroup | Timm Schneider | $13 | $10.12 | -46.6% | Jul 13, 2021 |
| TD Securities | Linda Ezergailis | $13.5 | $10.51 | -44.5% | Jul 6, 2021 |
| Goldman Sachs | Michael Lapides | $11 | $8.59 | -54.8% | Apr 27, 2021 |
Track every rating change on PAA the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationPlains All American Pipeline, L.P., through its subsidiaries, engages in the pipeline transportation, terminalling, storage, and gathering of crude oil and natural gas liquids (NGL) in the United States and Canada. The company operates through two segments, Crude Oil and NGL. The Crude Oil segment offers gathering and transporting crude oil through pipelines, trucks, and on barges or railcars. This segment provides terminalling, storage, and other related services, as well as merchant activities. The NGL segment is involved in natural gas processing and NGL fractionation, storage, transportation, and terminaling. This segment also includes ethane, propane, normal butane, iso-butane, and natural gasoline derived from natural gas production and processing activities, as well as crude oil refining processes. Its NGL components are used for various applications, such as heating, engine, and industrial fuels.The company was founded in 1981 and is headquartered in Houston, Texas. Plains All American Pipeline, L.P. operates as a subsidiary of Plains GP Holdings, L.P.
Historical context
All PAA earningsLatest beats and misses
Who reports nextBeat on EPS
Get the PAA recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-11T16:55:58.654741+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-11T16:55:58.652037+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-11. For educational purposes only; not investment advice.